These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30239214)

  • 1. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age.
    Ly TT; Layne JE; Huyett LM; Nazzaro D; O'Connor JB
    J Diabetes Sci Technol; 2019 Jan; 13(1):20-26. PubMed ID: 30239214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Bluetooth-Enabled Tubeless Insulin Pump: A User Experience Design Approach for a Connected Digital Diabetes Management Platform.
    Pillalamarri SS; Huyett LM; Abdel-Malek A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1132-1142. PubMed ID: 30304951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concept and Implementation of a Novel Patch Pump for Insulin Delivery.
    Ulbrich S; Waldenmaier D; Haug C; Freckmann G; Rendschmidt T; Künsting T
    J Diabetes Sci Technol; 2020 Mar; 14(2):324-327. PubMed ID: 31452394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
    Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes.
    Lebenthal Y; Lazar L; Benzaquen H; Shalitin S; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):411-7. PubMed ID: 22283640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the Omnipod
    Cobry EC; Berget C; Messer LH; Forlenza GP
    Ther Deliv; 2020 Aug; 11(8):507-519. PubMed ID: 32723002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
    Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the Omnipod Insulin Management System on Glycemic Control in Patients With Type 1 Diabetes Previously Treated With Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion.
    Layne JE; Parkin CG; Zisser H
    J Diabetes Sci Technol; 2016 Sep; 10(5):1130-5. PubMed ID: 27290737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
    Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
    Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Biester T; Schwandt A; Heidtmann B; Rami-Merhar B; Haak T; Festa A; Kostow S; Müller A; Mönkemöller K; Danne T;
    Diabetes Technol Ther; 2021 Aug; 23(8):527-536. PubMed ID: 33684335
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of OMNIPOD® on the quality of life of adolescents with type 1 diabetes.
    Nivet E; Lo G; Nivot-Adamiak S; Guitteny MA; De Kerdanet M
    Arch Pediatr; 2022 Jan; 29(1):21-26. PubMed ID: 34753634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can integrated technology improve self-care behavior in youth with type 1 diabetes? A randomized crossover trial of automated pump function.
    Neylon OM; O'Connell MA; Donath SM; Cameron FJ
    J Diabetes Sci Technol; 2014 Sep; 8(5):998-1004. PubMed ID: 25172877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The OmniPod Insulin Management System: the latest innovation in insulin pump therapy.
    Zisser HC
    Diabetes Ther; 2010 Aug; 1(1):10-24. PubMed ID: 22127670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial.
    Ramotowska A; Szypowska A
    Diabetes Metab Res Rev; 2014 Feb; 30(2):146-53. PubMed ID: 24115314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.